Searched for
US STRATEGIC ACTIVE PHARMACEUTICAL INGREDIENTS RESERVE
Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump saysNine pharmaceutical firms reached deals with the Trump administration for lower drug prices. These agreements expand the total number of co...- ONGC to enter oil trading, build strategic reserves as upstream remains coreONGC plans to enter crude and petroleum product trading operations soon. A new strategic petroleum reserve will be built in Mangalore. Expl...
- Trump to replenish US oil reserves with Venezuelan crude; 'topping out' process to begin shortlyDonald Trump announced plans to refill the Strategic Petroleum Reserve. He stated Venezuelan oil would be used for this replenishment effor...
- India, Uzbekistan step up strategic ties, seal long-term Uranium dealIndia and Uzbekistan will expand strategic cooperation in digital technology and AI. They will also enhance collaboration in outer space ex...
- Aurobindo Pharma gains over 3% as subsidiary launches generic Advair Diskus in US; stock up 41% YTDAurobindo Pharma shares rose sharply after its subsidiary Lannett Company launched the generic equivalent of Advair Diskus in the US. The i...
- Zomato bans analogue dairy dishes on platform, asks restaurants to take corrective actionZomato has implemented a strict zero-tolerance policy regarding analogue dairy dishes, also known as synthetic or fake dishes. Restaurants ...
- US to take 35% stake in Venezuelan mogul Betancourt's oil venture: ReportThe US government plans a 35% passive stake in Alejandro Betancourt's energy company. It also seeks preferential rights to purchase 20% of ...
- RBI plans buyback of Rs 30,000 crore G-SecsThe Reserve Bank of India has announced a buyback of government securities amounting to Rs 30,000 crore, targeting those set to mature in t...
- Trump administration weighs US ownership stake in Venezuela’s vast oil reserves: ReportThe Trump administration is discussing a potential US ownership stake in Venezuela’s oil industry, Axios reported, covering more than a doz...
- Symbiotec Pharmalab IPO Day 4: GMP at 29%, subscription reaches 5.31xSymbiotec Pharmalab's IPO saw strong investor demand, closing oversubscribed 71.26 times. The company aimed to raise Rs 1,757 crore through...
- At Septime, fine dining learns to whisperSeptime, a Paris bistro, offers fine dining with seasonal ingredients. Chef Bertrand Grebaut focuses on ingredient character and restraint ...
- Symbiotec Pharmalab IPO Day 2: GMP signals 34% upside — Should you subscribe?Symbiotec Pharmalab's IPO saw robust investor demand, with the issue subscribed 1.85 times. The company aims to raise Rs 1,757 crore throug...
- Food prices on the rise, domestic demand keeps economy strongIndia's economy shows resilience with improved domestic demand and strong economic activity. Food prices have seen a broad-based increase, ...
- Broad-base rise in food prices despite monsoon recovery, RBI's state of economy report showsIndia's economy shows resilience with improved domestic demand and strong activity. Food prices have seen a broad-based increase, impacting...
- Symbiotec Pharmalab’s Rs 1,757 crore IPO opens with GMP hinting at 41% upside. Should you bid?Symbiotec Pharmalab IPO GMP: Symbiotec Pharmalab’s Rs 1,757 crore IPO opened August 24, with a Rs 938–988 price band and 41% grey-market pr...
- Can Symbiotec Pharmalab IPO deliver long-term growth for high-risk investors?Symbiotec Pharmalab plans a ₹150 crore IPO to repay debt and expand operations. The company holds a global leadership position in corticost...
- Rs 3,300 crore IPO week: Symbiotec, Skyways Air to lead 10-offer rush for investorsIndia's IPO market is set for a busy week, with 10 companies, including Symbiotec Pharmalab, Skyways Air Services, Hy-Tech Engineers and Lu...
- Symbiotec Pharmalab gets Rs 526 crore anchor backing ahead of IPO; Citi Group, Singularity among investorsSymbiotec Pharmalab has raised Rs 526.20 crore from anchor investors ahead of its Rs 1,757 crore IPO opening August 24. The pharmaceutical ...
- Delhi High Court rules in favour of Dr Reddy's Labs in trademark row with RazentaThe Delhi High Court ordered the removal of Razenta Pharmaceuticals' Daplogin trademark. This decision came as the mark was deemed deceptiv...
- Symbiotec Pharmalab sets price band for Rs 1,757 crore IPO, to open on August 24Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 1...
Load More
